Related Experiment Video
Updated: Dec 27, 2025
Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
Hearing Preservation Outcomes and Prognostic Factors in Acoustic Neuroma Surgery: Predicting Cutoffs
Elisabetta Zanoletti1, Antonio Mazzoni1, Anna Chiara Frigo2
1Otorhinolaryngology Unit, Department of Neuroscience.
Objective:
To investigate the outcomes of hearing preservation surgery (HPS) for acoustic neuroma and quantify tumor and patient characteristics predictive of hearing preservation after surgery.
Study Design:
Retrospective study.
Setting:
Tertiary referral center.
Patients:
A total of 100 consecutive patients diagnosed with acoustic neuroma from 2000 to 2012.
Intervention:
Hearing preservation surgery through microscopic retrosigmoid approach combined with a retrolabyrinthine meatotomy.
Main Outcome Measure:
Pre- and postoperative hearing stratified according to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the Tokyo classifications. The most accurate cutoff was identified for each tumor and patients' variable affecting the outcome by calculating the Youden index. A multivariable analysis was undertaken at these cutoffs to identify prognostic factors for hearing preservation.
Results:
Preoperative hearing class was preserved after surgery in 31% (AAO-HNS), and 39% (Tokyo classification) of patients. According to the AAO-HNS classification, the tumor size in the cerebello-pontine angle, pure-tone average (PTA), and speech discrimination score cutoffs for predicting good postoperative hearing function were 7 mm, 21 dB, and 90%, respectively. With the Tokyo classification, only the PTA cutoff differed, with 27 dB. On multivariable analysis, tumor size and PTA were independent prognostic factors for postoperative hearing with high model's goodness of fit (area under the curve = 0.784; 95% CI = 0.68-0.88 and area under the curve = 0.813; 95% CI = 0.72-0.90), according to both the hearing classifications.
Conclusions:
The estimated cutoffs for tumor size and PTA were independently associated with HPS. These factors should be prospectively investigated before they are adopted as selection criteria for HPS.
